Dr Hadija Hamisi Semvua
| Call | Career Development Fellowship (CDF) |
| Programme | EDCTP2 |
| Start Date | 2019-07-01 |
| End Date | 2023-12-31 |
| Project Code | TMA2017CDF-1876 |
| Status | Active |
Title
Evaluation of Pharmacokinetics and Safety/Tolerability of Higher Doses of Rifampicin in Children with Newly Diagnosed, Uncomplicated Tuberculosis
Host Organisation
| Institution | Country |
|---|---|
| Kilimanjaro Clinical Research Institute (KCRI) | Tanzania, United Republic of |
Current Organisation
Kilimanjaro Clinical Research Institute
Current Job Title
Head-Clinical Trial Unit
Awards
| 2017 | Carrier Development Fellowship |
| 2018 | Carrier Development Award-THRIVE consortium |
| 2021 | RSTMH small grant award |
Students Supervised
| Type | Name | Title | University | Start Date | End Date |
|---|---|---|---|---|---|
| PhD | Arnold Ndaro | Mr | Radboud University | 2019 | 2024 |
| Master | Hamidu Rajabu | Mr | MUHAS-Tanzania | 2021 | 2023 |
| PhD | Alexander Mbuya | Dr | KCMUCo | 2021 | 2025 |
Memberships
| Role | Committee/board | Start Date | End Date |
|---|---|---|---|
| Study conduct | TSC | 2019 | 2023 |
| Pharmacist | Pharmacy Council | 2003 |
Education
| Institution | Degree | Year |
|---|---|---|
| University of Dar es salaam, Tanzania, United Republic of | BPharm | 1995-12-03 |
| KCMCUo, Tanzania, United Republic of | MPH | 2006-11-06 |
| Radboud University, Netherlands | PhD | 2014-04-26 |
Areas Of Specialisation
Tuberculosis (TB)
Grants
Publications
Projects
Fellow:
Hadija Hamisi Semvua
Collaborators:
| Name | Country | Institution |
|---|---|---|
| Hadija Semvua | Tanzania, United Republic of | KCMUCo |
Objectives:
To assess the pharmacokinetic safety/tolerability of high dose rifampicin in children aged 1-14 year with tuberculosis
Sites:
KCMC, HYDOM, HURUMA HOSPITAL
Study Design:
Phase 2 A dose ranging study
Subjects:
Children aged 2-14 years
Outcomes:
safety and efficacy achieved compared to the adult study
Start Date:
2019-07-01
End Date:
2023-12-31